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Abstract
Despite advances in neonatal care,  infants with omphalocele have a mortality rate
ranging between 5% and 25%. Respiratory insufficiency is a common clinical chal‐
lenge  and  an  independent  predictor  of  mortality  in  these  infants.  The  causes  of
respiratory failure are diverse and are not well understood. This chapter discusses the
unique aspects of respiratory management in omphalocele infants. The authors have
chosen references in this chapter with appropriate sample size, variable comparisons,
regression analyses, and documented median follow-up times. Omphalocele is rare;
therefore, the case reports of chapter references have important information.
Omphalocele infants are sometimes born with inadequate lung volume to support
survival. Prenatal predictors of pulmonary hypoplasia are discussed in the context of
fetal magnetic resonance imaging (MRI) and postnatal clinical-radiologic correlation
studies.  Two recent retrospective articles explain the unique aspects of pulmonary
hypertension in omphalocele infants and distinguish it from pulmonary hypoplasia.
The avoidance of abdominal compartment syndrome at the time of omphalocele closure
is discussed. Clinical strategies that improve the respiratory care of these infants, based
on Specific definitions and diagnoses, may reduce the high mortality rate.
Keywords: respiratory insufficiency, pulmonary hypoplasia, pulmonary hyperten‐
sion, abdominal compartment syndrome, extracorporeal membrane oxygenator, de‐
layed repair
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1. Introduction
Omphalocele is a congenital ventral defect of the umbilical ring with herniation of the
abdominal viscera. The reported incidence is 1 in 6000 live births [1]. If omphalocele is
diagnosed in the first trimester, over 30% of fetuses die in utero [2, 3]. Despite advances in
neonatal care, for live-born infants, the mortality rate remains between 5% and 25% [4].
Postnatal management includes protection of the herniated viscera, prevention of hypother‐
mia, gastric decompression, and maintenance of cardiopulmonary stability [5].
Respiratory insufficiency at birth is reported as an independent predictor of mortality for
infants with omphalocele, but the causes are diverse [1]. Respiratory insufficiency in neonates
is generally defined as hypoxemia in room air with progressive respiratory and metabolic
acidosis and the need for mechanical ventilation within 24 hours of birth [1].
In this chapter, giant and nongiant omphaloceles are compared, as giant omphalocele infants
have a more complex postnatal course and more respiratory difficulties.
Prenatal predictors of postnatal respiratory failure and unique clinical care strategies are
discussed. Pulmonary hypoplasia is defined. Historically, fetuses and infants with omphalo‐
cele are reported to have markedly reduced chest capacities. Recently, fetal magnetic resonance
imaging (MRI) has expanded the understanding of decreased congenital lung volume in
infants with omphaloceles. Clinical-radiologic correlation studies support the use of prenatal
MRI to predict the degree of respiratory insufficiency observed in the postnatal period.
The contribution of major anomalies to respiratory difficulties is discussed.
Infants with omphalocele may have increased pulmonary vascular reactivity and pulmonary
hypertension that increases the postnatal mortality risk. In this chapter, pulmonary hypoplasia
and pulmonary hypertension are defined as distinct entities. The chapter emphasizes that the
two diagnoses must be distinguished from each other in the clinical setting. Each has different
clinical implications and care strategies.
The implications of congenital heart defects in omphalocele infants are explained. The roles
and goals of assisted ventilation for respiratory insufficiency in omphalocele infants are
expanded.
Since 2011, a small number of infants with omphalocele and respiratory insufficiency have
required the extra-corporeal membrane oxygenator (ECMO) for respiratory failure. This
chapter provides the first review of the Extra-corporeal Life Support Organization (ELSO, Ann
Arbor, MI, USA) database for the causes of respiratory failure and outcomes in omphalocele
infants place on ECMO.
The timing of surgical repair and postoperative complications, such as compartment syn‐
drome, delayed surgical closure techniques, and the implications of a ruptured omphalocele,
are explained.
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Pulmonary function abnormalities, chronic lung disease, the role of tracheostomy, the
influence of gastroesophageal reflux disease (GERD), prematurity, and strategies to improve
outcomes, are discussed.
2. Giant omphalocele
Giant omphalocele represents an important subset of omphalocele infants. Giant omphalocele
is defined as an omphalocele defect containing greater than 75% liver in the sac, and/or a
diameter greater than 5 cm [4, 6]. A nongiant omphalocele is generally defined as a defect with
diameter less than 5 cm. Previous definitions that measured the defect in centimeters do not
account for the differences in size and gestational age of infants.
The definition that giant omphalocele is a defect that contains greater than 75% liver in the sac
is preferable and uniform [4]. Giant omphalocele is associated with poor prognosis in many
studies. Giant omphalocele is often associated with a greater incidence of respiratory insuffi‐
ciency, longer ventilator requirements, and an increased incidence of pulmonary hypoplasia
and pulmonary hypertension [6, 7].
Infants with giant omphaloceles have significantly more neonatal morbidity. When large and
small omphaloceles are compared, the median length of stay (47 vs. 10 days), median age at
full enteral feeds (23 vs. 5 days), median duration of mechanical ventilation (23 vs.7 days), and
requirement of supplemental oxygen at 30 days of life (88% vs. 27%) are significantly longer
for infants with giant omphaloceles [7].
Respiratory failure is the major cause of mortality in infants with giant omphaloceles [8]. In
the neonatal period, these infants have significantly more pulmonary hypoplasia and pulmo‐
nary hypertension and therefore, more respiratory difficulties [4, 7, 9]. Lung preservation
ventilation strategies are emphasized in infants with giant omphaloceles. The overall in-
hospital mortality for infants with giant omphaloceles approaches 20% [6].
After the neonatal period, giant omphalocele infants have more chronic lung disease and
gastroesophageal reflux. In contrast, small omphaloceles generally have a good prognosis
when they are not associated with lethal malformations or congenital syndromes [5].
Most minor defects are closed primarily. Because of the preponderance for respiratory
insufficiency in infants with giant omphaloceles, however, there is more controversy regarding
closure techniques.
Infants with giant omphaloceles have suboptimal neurodevelopmental outcomes. Their
difficult early course frequently includes hypoxia, acidosis, hypotension during delivery, a
long duration of mechanical ventilation, infection, and prolonged hospitalization. These
factors all compound and play a role in determining neurologic outcomes.
Giant omphalocele survivors tend to have more significant neurodevelopmental delay than
children with other congenital anomalies such as congenital diaphragmatic hernia or congen‐
ital heart defects. They appear similar in their neurocognitive outcomes to preterm newborns
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that develop severe bronchopulmonary dysplasia. This further emphasizes the importance of
optimal respiratory management and an understanding of the goals of assisted ventilation for
infants with giant omphaloceles [6].
3. Pulmonary hypoplasia and the role of fetal magnetic resonance
imaging
Lung hypoplasia is defined as insufficient development of pulmonary airways, alveoli, and
vessels [10]. Historically, plain chest radiographs of omphalocele infants revealed a narrow
thorax and curved ribs. Measures of chest width and lung area were significantly smaller in
giant omphalocele infants. Such abnormalities of lung growth may be the result of a defor‐
mation sequence in utero. The liver is displaced in giant omphaloceles and so does not mold
the thoracic cage [11–13].
Subsequently, prenatal ultrasound was used to calculate observed/expected lung volumes for
fetuses. Two-dimensional ultrasound measured the lung-to-thorax ratio and predicted
pulmonary hypoplasia. However, some report the assessment as inaccurate [14]. Three-
dimensional ultrasound has improved sensitivity in normal amniotic fluid volume but not
oligohydramnios [15, 16].
Presently, fetal magnetic resonance imaging studies have established a curve of normal fetal
lung volume values plotted against gestational age [17]. The measured fetal lung volume is
divided by the expected mean fetal lung volume for a given gestational age or fetal body
volume to obtain the observed/expected total fetal lung volume (O/E-TFLV) ratio [17].
Accurate measurement of fetal lung volume has important clinical applications. Fetal magnetic
resonance imaging has shown that lung volumes are only 50% of the predicted values in some
prematurely born omphalocele infants with large defects. Such infants have lower Apgar
scores and require prolonged ventilator support [18].
When infants with congenital lung malformations (CLMs), congenital diaphragmatic hernias
(CDHs), or omphaloceles and an O/E-TFLV of 40% to 60% are compared, the need for ECMO,
the use of supplemental oxygen at 30 days of life, and the 6-month mortality are similar among
the three groups (Table 1) [19].
Variable CDH
n = 27
Omphalocele
n = 13
CLM
n = 16
p-value
Length of intubation, days
median (IQR)
9.0 (7–17) 0 (0–6)* 0 (0–1.3)* <0.001
Length of hospital stay, days
median (IQR)
29.0 (22–55) 30.5 (15–47) 8.0 (3–20)*# 0.009
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Variable CDH
n = 27
Omphalocele
n = 13
CLM
n = 16
p-value
Pulmonary HTN,
n (%)
11/27 (40.7%) 0/13 (0%)* 0/16 (0%)* 0.001
Treatment of pulmonary HTN
n (%)
7/27 (25.9%) 0/13 (0%) 0/16 (0%)* 0.014
iNO utilization
n (%)
4/27 (14.8%) 0/13 (0%) 0/16 (0%) 0.099
ECMO
n (%)
1/27 (3.7%) 0/13 (0%) 0/16 (0%) 0.579
Supplemental oxygen at 30 DOL
n (%)
7/27 (25.9%) 3/13 (23.1%) 1/16 (6.3%) 0.274
Mortality at 6 months
n (%)
0/27 (0%) 1/13 (7.7%) 0/16 (0%) 0.234
IQR: interquartile range; HTN: hypertension; iNO: inhaled nitric oxide; ECMO: extra-corporeal membrane
oxygenation; supplemental O2 at 30 DOL: supplemental oxygen at 30 days of life
*p < 0.05 vs. CDH.
#p < 0.05 vs. OM.
Table 1. Outcomes of congenital diaphragmatic hernia (CDH), omphalocele (OM), and congenital lung malformation
(CLM) in infants with fetal lung volumes between 40% and 60% of predicted values [19].
In fetuses with CLM, an O/E-TFLV of less than 75% after 26 weeks predicts a difficult postnatal
course that includes increased respiratory distress, a need for intubation, and lung mass
excision [20].
Infants with CDH generally have O/E-TFLV measurements ranging from less than 25% to 45%.
They require more pulmonary support than omphalocele and congenital lung malformation
infants. Clinical-radiologic correlation studies support the use of prenatal MRI to predict the
perinatal and postnatal courses in neonates with CDH. The measurements have also been used
to guide the fetal therapy with improved postnatal results. Ratios less than 35% are associated
with an increased use of ECMO and a higher mortality [21].
A series of infants with giant omphaloceles compare those with less than 50% to infants with
greater than 50% O/E-TFLV at 26 to 31 weeks gestational age. Infants with less than 50% O/E-
TFLV have significantly lower Apgar scores at birth, prolonged ventilation, and a longer
hospitalization. MRI-based O/E-TFLV of less than 50% is considered predictive of increased
postnatal morbidity in giant omphalocele infants [18].
A precise quantification of compromised fetal lung development in omphalocele infants may
improve perinatal and postnatal management. Fetal magnetic resonance imaging after 26
weeks gestational age and calculation of the O/E-TFLV is recommended.
Respiratory Management of the Newborn with an Omphalocele
http://dx.doi.org/10.5772/63735
29
Similar to CDH and CLM, this calculation reflects pulmonary hypoplasia and allows clinicians
to prepare for increased respiratory distress, a need for intubation after birth, and chronic
ventilator support. Similar to CDH, further studies may prove that it prognosticates for ECMO
use and for mortality. Detailed prenatal counseling and realistic expectations can be provided.
For infants that do not survive, lung-volume-to-body-weight ratios have been established for
term and preterm infants [10]. Assessment of lung growth is a critical component of perinatal
autopsy. One single series review reports lung biopsy or autopsy pathologic diagnosis of
pulmonary hypoplasia or pulmonary hypertension in five omphalocele cases but does not
expand on the precise histology details [7].
Fetal magnetic resonance lung volume curves and pathologic lung-volume-to-body-weight
ratios for gestational age exist, but clinical-pathologic correlation studies are needed to further
characterize pulmonary hypoplasia in infants with omphaloceles.
4. The contribution of major anomalies
Infants with major anomalies and omphaloceles have a longer duration of mechanical
ventilation, hospital stay and a need for oxygen at 30 days of life. In a single-institution series
of 82 live-born infants, 26% had chromosomal and 30% had major associated anomalies. None
of the 19 live-born infants with an isolated defect died. Mortality, however, was 41% and 17%
for those with major and minor anomalies, respectively [22].
The presence of associated anomalies is a strong predictor of morbidity and mortality, and
anomalies are also linked to respiratory status [5, 16, 23].
Beckwith-Wiedemann syndrome is characterized by omphalocele, macroglossia, macrosomia,
hypoglycemia, and embryonic tumors. It is a growth disorder due to dysregulation of the
growth regulatory gene on chromosome 11p15 [23]. The presence of hypoglycemia in the
perinatal period should alert the clinician to the possibility of Beckwith-Wiedemann syn‐
drome.
The finding of omphalocele on a prenatal ultrasound should prompt a search for associated
anomalies and possible further prenatal testing. In a large prenatal study of 445 fetuses with
omphalocele, diagnosed in the first trimester, only 55 were live born. Over 85% died in utero
due to the presence of fatal chromosomal anomalies [2, 3].
The presence of omphalocele indicates an increased risk of aneuploidy. In a recent first
trimester study, fetuses with an omphalocele were found to carry a chromosomal abnormality
in 55% of cases [16]. The most frequent abnormal karyotypes in omphalocele infants are
Trisomy 18 and 13 [24]. Both have almost 100% incidence of congenital heart defects, including
ventricular septal defect, atrial septal defect, and double outlet right ventricle. Infants with
omphaloceles, in the setting of Trisomy 13 or 18 and a congenital heart defect, tend to have
severe hemodynamic compromise.
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In the setting of omphalocele and major anomalies, the cardiopulmonary support provided
by the clinician is intensified [25].
Congenital diaphragmatic hernia is sporadically reported in conjunction with an omphalocele.
Careful review of fetal MRI of the diaphragm may identify congenital diaphragmatic hernia.
Conflicting reports exist, but generally pulmonary hypertension is profound and the outcome
is poor [7, 26]. Elevated hemidiaphragms, diaphragmatic eventration, and congenital dia‐
phragmatic hernia have been described in infants with giant omphaloceles, and could
contribute to impaired lung development and postnatal distress [8, 11, 27].
5. Pulmonary hypertension
Previously, nonspecific respiratory insufficiency at birth was reported as an independent
predictor of mortality for infants with omphaloceles. Older reports do not distinguish between
pulmonary hypertension and pulmonary hypoplasia in their contribution to ventilation
difficulties.
Pulmonary hypertension is now established as an independent predictor of mortality in infants
with omphaloceles [28]. One recent series found that mortality was highest for live-born infants
with omphaloceles diagnosed with pulmonary hypertension (45%), considerably higher than
mortality in a cohort of infants with omphaloceles alone (18%) [29]. The contribution of
pulmonary hypertension to respiratory insufficiency was previously unappreciated [28].
Pulmonary hypertension is diagnosed using echocardiography performed after the second
day of life. Changes in the transitional circulation on the first day of life preclude evaluation
for pulmonary hypertension by echocardiography. Directionality of flow through the ductus
arteriosus is not considered in the diagnosis of pulmonary hypertension on the first day of life.
Pulmonary hypertension is defined on echocardiography as flattening of the interventricular
septum during systole and/or a tricuspid regurgitant jet (TR) with an estimated right ventric‐
ular pressure greater than 40 mmHg when observed in the setting of hypoxemia [28, 30].
Qualitative measures of right-sided stress, as determined by the cardiologist interpreting the
study, contribute to the assessment. These are right ventricular dilation, right atrial enlarge‐
ment, right ventricular hypertrophy, septal flattening, and pulmonary artery dilation [28, 30,
31].
The incidence of pulmonary hypertension is reported in 37 to 55% of infants with giant
omphaloceles. It is more prevalent in infants with additional anomalies [28, 31]. The explana‐
tion, whether structural, oxygen tension related, genetic, or some other cause, remains
unknown.
Pulmonary hypertension correlates to endpoints of pulmonary insufficiency, including
duration of mechanical ventilation, requirement for high-frequency oscillator ventilation, need
for tracheostomy, and reliance on oxygen at the time of discharge from neonatal intensive care
unit [31].
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Conflicting reports exist regarding the prognosis of infants with giant omphaloceles. Some
have mild respiratory distress, achieve early feeding and undergo delayed fascial closure with
good results [28]. In contrast, others report a high mortality rate in giant omphalocele infants,
relating to the predominance of respiratory insufficiency and pulmonary hypertension.
Several retrospective studies suggest that there may be a direct relationship between giant
defects and abnormal pulmonary vascular tone. Clinicians should not focus on the defect
diameter, but recognize that respiratory insufficiency and pulmonary hypertension are the
prognosticators to identify [8, 18, 32].
A recent multicenter retrospective review illustrates the distribution of respiratory insuffi‐
ciency and pulmonary hypertension in 51 infants with omphalocele (Figure 1). All 51 had
echocardiography performed between the day of life 2 and 7 [28].
Sixteen infants (31%) had no pulmonary hypertension and no respiratory insufficiency at birth.
Of these, 15 survived (94%) and 1 died (6%).
Of the 51 infants (55%), 28 had pulmonary hypertension, and of these, 13 had respiratory
insufficiency (46%) while 15 did not (54%).
Of the 51 (39%), 20 infants had respiratory insufficiency at birth without detectable pulmonary
hypertension. Six of twenty (30%) were premature infants with a mean gestational age of 31.7
weeks.
Ninety-two percent of mortalities in the cohort were distributed among the infants with
pulmonary hypertension, with or without respiratory failure, or respiratory failure without
pulmonary hypertension. Of 38 survivors, one that initially presented with respiratory
insufficiency, without pulmonary hypertension, progressed to chronic lung disease and
required a tracheostomy and a long-term ventilator support. Of the 15 infants with isolated
Figure 1. The distribution of respiratory failure and pulmonary hypertension in 51 infants with omphaloceles.
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pulmonary hypertension and no evidence of respiratory insufficiency, 13 survived (87%), and
none required long-term ventilation (Figure 1).
Giant omphalocele defects containing 75% liver were closely associated with mortality. The
distribution of 17 giant defects is illustrated among the cohort in Figure 1. Eight of seventeen
(47%) died, and the eight deaths with giant defects were all distributed in the nine infant deaths
that had a combination of pulmonary hypertension and respiratory failure at birth (89%). The
distribution of the remaining giant defects is illustrated among the survivors (Figure 1) [28].
Logistic regression analysis further revealed that both respiratory insufficiency at birth (OR:
14.8; 95% CI: 2.5–85.0) and pulmonary hypertension diagnosed between days 2 and 7 of life
(OR: 6.4; 95% CI: 1.1–39.0) were independently associated with mortality in infants with
omphaloceles. This is a new and previously unappreciated finding.
A clinical care strategy that screens for pulmonary hypertension in omphalocele infants is
recommended. Echocardiography is best performed between the second and seventh day of
life to avoid examination during transitional circulation. Echocardiography should be
performed at regular intervals until resolution or stabilization of pulmonary hypertension is
demonstrated [28, 30].
The aims of pharmacotherapy for pulmonary hypertension are pulmonary vasodilation,
restoration of normal endothelial function, and reversal of remodeling of the pulmonary
vasculature. All of these therapies reduce right ventricular afterload and prevent right
ventricular failure. Pulmonary vasodilation is needed acutely for pulmonary hypertension,
but long-term therapy may focus on vascular remodeling. The main therapies for pulmonary
hypertension emphasize the nitric oxide, prostacyclin, and endothelin pathways [33].
There are sporadic reports of the use of ventilator support with inhaled nitric oxide to treat
omphalocele infants with pulmonary hypertension. However, detailed reports of lung
function measurements before and after trials of inhaled nitric oxide that establish vascular
reactivity are few [25]. The phosphodiesterase inhibitor and vasodilator, sildenafil, is admin‐
istered with success in sporadic series.
After nitric oxide, sildenafil is considered the next-line therapy for pulmonary hypertension
in infants, irrespective of etiology [31, 34]. Sildenafil generally improves the oxygenation index
with minimal adverse effects in infants with pulmonary hypertension. Despite sildenafil,
however, abnormal vascular tone does not necessarily resolve. One-quarter of giant ompha‐
locele infants may require long-term vasodilator therapy with sildenafil [31].
We report one case of giant omphalocele treated with sildenafil and Bosentan. Echo performed
at age 4 years shows that the pulmonary hypertension has completely resolved. Bosentan is
an oral endothelin receptor antagonist that inhibits vascular remodeling and muscular
thickening. Endothelin-1 is believed to play a role in the pathogenesis of neonatal pulmonary
hypertension, and endothelin blockade augments pulmonary vasodilation in the perinatal
lung. Several reports have shown that Bosentan provides benefit in the treatment of pulmonary
hypertension in infants [33].
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Selected fetuses may benefit from a maternal hyperoxia study prenatally to predict who will
be at risk for elevated pulmonary vascular resistance and pulmonary hypertension, similar to
prenatal evaluation in congenital diaphragmatic hernia [25, 35, 36].
The biology of neonatal pulmonary hypertension is linked to lung vascular growth modified
by prenatal and early postnatal factors. The use of medical therapy to modify pulmonary
hypertension in omphalocele infants is an important area of future study [37].
6. Congenital heart defects
The anterior abdominal wall develops between weeks 3 and 10 of fetal development. The
process involves folding of the embryonic disk in cranio-caudal and lateral directions. By week
6 of fetal development, the elongated midgut herniates into the base of the umbilical cord due
to lack of space in the abdominal cavity. By the tenth week, it rotates and returns to the
abdomen. During this period, the cardiac tubes, which lie on the ventral surface of the embryo,
are incorporated into the chest by the lateral folds. Errors in these critical steps of fetal
development result in simultaneous anterior abdominal wall defects, such as omphalocele,
and structural cardiac defects [25].
In general, a single- or multiinstitutional series of live-born infants with omphaloceles report
a 30% incidence of structural congenital heart defects. Neonates with patent ductus arteriosus
or patent foramen ovale are not considered to have a congenital heart defect.
A single-center retrospective series found that of 22 live-born omphalocele infants, 7 had
evidence of a structural congenital heart defect, 4 of which developed pulmonary hyperten‐
sion, and 1 of the 4 also had a dysplastic tricuspid valve. Only one infant required a surgical
repair, and that infant presented with coarctation of the aorta [25]. The incidence of structural
cardiac defects was lower than expected, and this was attributed to the low incidence of
abnormal karyotypes.
Another recent multicenter series reports a congenital heart defect incidence in omphalocele
infants of 30%, but all were nonductal-dependent lesions without hemodynamic compromise.
None had cardiac failure [28].
Although structural cardiac defects should be specifically sought by echo in the first week of
life, the influence of congenital heart defects on the outcome for omphalocele infants may be
lower than expected, in particular if the cohort has normal karyotypes.
Although clinicians previously evaluated for congenital heart defects, they did not evaluate
for pulmonary hypertension. Recent reports clarify that pulmonary hypertension likely has a
greater influence on the outcome and mortality in omphalocele infants than congenital heart
defects, unless Trisomy 13 or 18 is diagnosed.
In the setting of Trisomy 13 or 18, the incidence of congenital heart defects is over 90%. The
most common defects are ventricular septal defect, atrial septal defect, and double outlet right
ventricle.
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The congenital heart defects of these chromosomal anomalies tend to present with hemody‐
namic compromise [25, 28, 38]. The establishment of regional and national databases for
omphalocele would enhance the statistical understanding of the true incidence of congenital
heart defects and hemodynamic compromise in omphalocele infants as few detailed reports
with large sample size exist.
7. Respiratory insufficiency and assisted ventilation
Assisted ventilation may be necessary in neonates with omphalocele due to respiratory
insufficiency from pulmonary hypoplasia, increased abdominal pressure following surgical
repair, diaphragm dysfunction, and pulmonary hypertension [39]. The need for assisted
ventilation may occur at delivery or may be confined to the immediate postoperative period
related to increased intraabdominal pressure and upward displacement of the diaphragm
following closure.
7.1. Goals of assisted ventilation
The goal of assisted ventilation in neonates with respiratory insufficiency due to omphalocele
is to achieve adequate functional residual capacity to facilitate gas exchange. Assisted venti‐
lation should be applied to maintain adequate lung volume with even distribution of tidal
volume to avoid trauma from atelectasis and lung injury. If lungs with partial atelectasis are
ventilated, the tidal volume entering only the open alveoli will lead to overexpansion of the
relatively healthy portion of the lung with subsequent trauma due to overexpansion.
Additionally, atelectasis leads to vascular protein leak with increased surfactant inactivation
and release of inflammatory mediators. Maintaining adequate lung volume is achieved by
applying adequate positive end expiratory pressure (PEEP). There is no single optimal PEEP,
and the level must be tailored to the degree of lung injury. For infants with healthy lungs and
normal lung compliance, PEEP of 3–4 cm H2O may be appropriate. Excessive PEEP may lead
to overexpansion of normal lungs with circulatory impairment and elevated cerebral venous
pressure. However, poorly compliant lungs with atelectasis may transiently require higher
PEEP, as high as 8–10 cm H20 or more, to achieve adequate alveolar recruitment and optimize
ventilation/perfusion ratios [40].
For small omphaloceles, if primary abdominal closure has been accomplished, the majority of
neonates will require mechanical ventilation for a few days postoperatively. During this time,
the abdominal wall and bowel wall edema will improve, and the intraabdominal pressure will
decrease.
The elective, routine use of mechanical ventilation to ensure primary closure in every instance
is unwarranted. Short-term ventilator support, however, has been a welcomed adjunct to
postoperative care and certainly has improved the outlook for these infants [41].
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7.2. Noninvasive ventilation
Little information exists regarding the use of continuous positive airway pressure (CPAP) or
positive end expiratory pressure (PEEP) in stabilizing the lungs of infants with omphaloceles.
Positive end expiratory pressure has been used in premature infants to minimize the effect of
excessively compliant chest wall and surfactant deficiency by stabilizing alveoli during the
expiratory phase, and has been shown to help establish functional residual capacity.
Traditional management in neonates with omphalocele and respiratory insufficiency involves
intubation and mechanical ventilation in the delivery room to presumably avoid further
distention of bowel from air swallowing. However, nasal CPAP and/or nasal intermittent
positive pressure ventilation may be a preferable approach to improve inadequate respiratory
effort in these neonates, while avoiding the complications associated with endotracheal
intubation [42].
The noninvasive approach offers the benefit of avoiding an endotracheal tube; therefore,
reducing the incidence of ventilator-associated pneumonia and avoiding the contribution of
postnatal inflammatory response to the development of bronchopulmonary dysplasia.
Noninvasive ventilation reduces iatrogenic lung injury.
7.3. Conventional mechanical ventilation
Several modes of mechanical ventilation have been applied to neonates with omphalocele, but
there is little evidence to guide clinicians in selecting the best method. Historically, pressure-
controlled ventilation is the standard mode of ventilation in neonates with respiratory failure
because of its wide availability, simplicity, ability to ventilate despite large endotracheal tube
leak, and improved intrapulmonary gas distribution. However, pressure-controlled ventila‐
tion is limited, in that tidal volume varies with changes in lung compliance.
A rapid improvement in compliance may occur in the immediate postnatal period as a result
of resorption of lung fluid, recruitment of optimal lung volume, and surfactant replacement
therapy, leading to hyperventilation and trauma from excessive lung hyperexpansion [40].
Insufficient tidal volume may develop because of decreasing lung compliance, increasing
airway resistance, airway obstruction, air trapping, and/or decreased spontaneous respiratory
effort. Inadequate lung volume leads to hypercapnia, increased work of breathing and oxygen
consumption, agitation, fatigue and atelectasis/atelectrauma. Low tidal volume leads to
inefficient gas exchange due to increased dead space: tidal-volume ratio. Mechanical ventila‐
tion goals should include weaning toward extubation, as well as weaning supplemental FiO2,
in order to avoid oxygen toxicity that may contribute to chronic lung disease.
7.4. High-frequency ventilation
In selected infants with respiratory failure due to pulmonary hypoplasia and/or severe
pulmonary hypertension, high-frequency ventilation may optimize lung inflation and
improve gas exchange. High-frequency ventilation is beneficial as it reduces pressure and
volume swings transmitted to the periphery of the lungs, and promotes gentle ventilation. For
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optimal effectiveness, alveoli must be recruited and stabilized with the lowest possible mean
airway pressure.
There is little information in the literature describing the effectiveness of high-frequency
ventilation in neonates with omphalocele. In a large single-center series of giant omphalocele
infants, mechanical ventilation maintains preductal oxygen saturation above 85% and high-
frequency oscillatory ventilation is reserved for patients with refractory hypercapnia [41].
One report examines the use of high-frequency ventilation in 15 omphalocele infants after
surgical closure. Of 15 infants, 11 had not required ventilation and were breathing room air
prior to operation. High-frequency ventilation is reported as required in six infants (61%)
within the first week in the intensive care unit after omphalocele closure. The remainder were
managed with conventional ventilation. In half of the 15 infants, lung expansion on chest
radiograph was reported at 50%.
The average mean airway pressure at days 5–7 for both the conventional ventilation group
and the high-frequency group was 14 mmHg ± 3.0. Weaning from ventilation was achieved
on day 7 in only five of the omphalocele infants. Six required ventilation until day 28. Four
infants required tracheostomy and prolonged respiratory support between 330 and 1065 days
[38]. Prolonged duration of mechanical ventilation and use of parenteral nutrition during this
time period likely also contribute to an increased risk of infection.
Primary closure was the procedure of choice in this series. Despite the use of high-frequency
ventilation, this series reports a slightly lower survival rate of 73%, compared to the studies
with an emphasis on delayed closure that report survival rates of 80% or higher. They note
that tension was described by the surgeon in three closures and may have contributed to
postoperative difficulties. They note closure of the abdominal wall defect compromised
pulmonary mechanics when increased intraabdominal pressure inhibited diaphragmatic
movements as the viscera was reduced [38].
This study supports the existence of a degree of pulmonary hypoplasia and decreased
pulmonary reserve in omphalocele infants that could only be overcome to a degree by high-
frequency ventilation in some but not all of the infants that underwent early closure. It supports
the use of delayed closure techniques and careful evaluation of abdominal-visceral dispro‐
portion and cardiopulmonary status prior to proceeding with operation [38].
8. Extra-corporeal membrane oxygenation (ECMO)
Despite improvements in the management of respiratory insufficiency and pulmonary
hypertension in infants, a number of infants with inadequate gas exchange are treated with
extra-corporeal membrane oxygenation (ECMO). This includes infants with omphaloceles.
The authors retrospectively analyzed the Extra-corporeal Life Support Organization (ELSO,
Ann Arbor, MI, USA) database between 1992 and 2015 for extra-corporeal membrane oxy‐
genator (ECMO) use and omphalocele. ELSO membership consists of many major medical
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centers worldwide, with the capability of placing infants on ECMO. This database would
capture the majority of infants with omphaloceles, managed with ECMO, during the time
period and provide the most of the information about the use of ECMO in these infants. The
first infant with an omphalocele was placed on ECMO in 2011.
The specific diagnoses for respiratory insufficiency listed in the database are pulmonary
hypertension, congenital heart defects, congenital diaphragmatic hernia, and sepsis. The
recorded diagnoses for respiratory insufficiency in the 11 infants were isolated pulmonary
hypertension in three; congenital heart defect and pulmonary hypertension in five (one of the
five also had capillary alveolar dysplasia); congenital diaphragmatic hernia, congenital heart
defect, sepsis, and pulmonary hypertension in one; and congenital diaphragmatic hernia and
pulmonary hypertension in two infants.
The six congenital heart defects were double outlet right ventricle in two, Tetralogy of Fallot
in one, ventricular septal defect in one, cor triatriatum in one, and aortic atresia/stenosis in one.
Table 2 presents the demographic details and outcomes of 11 infants with omphaloceles placed
on ECMO between 2011 and 2015.
Omphalocele
N = 11
First recorded ECMO run 2011
ECMO after day of life 3 8 (73%)
Gender (male) 7 (64%)
Weight at ECMO (kg)a 3.27 (2.5–10)
Age at ECMO (days)a 10 (0–351)
Run length (hours)a 193 (11–589)
A diagnosis of PHN 11 (100%)
Veno-arterial ECMO 10 (91%)
Discontinued from ECMO alive 7 (64%)
Discharged from hospital alive 2 (18%)
Data are expressed in number (%) except with (a) data are expressed in median (range).
Table 2. Omphalocele infants that underwent ECMO (2011–2015).
This is a small but significant series as it provides the only data available at present for
omphalocele infants and the use of ECMO. The incidence of abnormal karyotypes is not
reported with the database, so any association with Trisomy 13 or 18 is unknown.
For infants with omphaloceles that underwent ECMO, between 2011 and 2015 and reported
in the ELSO database, the overall mortality was 80%. This high mortality rate contrasts to the
reports from a large multicenter series of infants that underwent ECMO for pulmonary
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hypertension and other conditions such as congenital diaphragmatic hernia between 2000 and
2010, where the mortality rate is 20% or better. These data support the need to better under‐
stand the underlying pathophysiology of pulmonary hypertension, so therapy can target its
causes in omphalocele infants. There is overlap in the diagnoses of respiratory insufficiency
in almost all cases of omphalocele placed on ECMO. Only a large study with multivariate
analysis could determine the contribution of each diagnosis to respiratory failure and mortality
in omphalocele infants.
One term infant with omphalocele, and respiratory insufficiency attributable to congenital
heart defect and pulmonary hypertension, underwent lung biopsy after 10 days of ECMO
support. The lung biopsy revealed capillary alveolar dysplasia. Extra-corporeal membrane
oxygenation was withdrawn due to the fatal prognosis.
This solitary report raises questions about the etiology of persistent pulmonary hypertension
in some omphalocele infants. More autopsy studies and published reports after examination
of omphalocele infant lungs may expand the understanding of the contribution of this disorder
to pulmonary hypertension and mortality.
Clinically, capillary alveolar dysplasia cannot be distinguished from other syndromes that
cause pulmonary hypertension. Histologically, it is characterized by paucity of capillaries
adjacent to alveolar epithelium, immature alveolar development, and muscularization of
arterioles. The distribution can be diffuse or patchy. The etiology and incidence of capillary
alveolar dysplasia are unknown [43].
9. Surgical considerations
The aim of surgical management in infants with omphaloceles is to avoid an abrupt increase
in the abdominal pressure that may impair ventilation. An omphalocele which is less than 4
cm in size may be suitable for primary repair after cardiopulmonary stabilization and assess‐
ment of anomalies. In contrast, if a giant omphalocele is closed too early, the intraabdominal
volume may be insufficient to contain the organs [4, 5].
Immediate postoperative complications are compromise of venous return from a sudden
increase in intra-abdominal pressure and cardiopulmonary instability from decreased
diaphragmatic excursion. The result is abdominal compartment syndrome (ACS) [38, 39].
Compartment syndrome due to increased intraabdominal pressure is a serious complication
after a difficult omphalocele reduction. Early series report a 12% incidence of complications,
including acute hepatic congestion, renal failure, and bowel infarction [5, 6].
Before the impact of viscero-abdominal disproportion (VAD) and abdominal compartment
syndrome was understood, surgeons placed emphasis on operative closure. Between 1980 and
1995, in a series of 30 operative closures, about half were small defects and were closed
primarily without complications [44].
The remainder were giant omphaloceles. Three underwent skin closure due to viscero-
abdominal disproportion. Thirteen underwent silo placement and were closed between 11 and
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137 days. There were 14 serious complications in 13 infants. All were due to initial tight closure,
and all were opened postoperatively. There was one postoperative death (Table 3).
No randomized studies show that intraabdominal pressure monitoring is beneficial, and
therefore it is not used to guide closure in the operating room, but may have a role in the
postoperative period. Continuous bladder pressure monitoring in the postoperative period
does not prevent necrotizing enterocolitis, but maintaining abdominal pressure below 20
mmHg prevents renal failure [45].
Various closure techniques for giant omphalocele exist, including alloderm patch, vacuum-
assisted closure, tissue expanders, silos, and other types of mesh materials [46, 47]. If the sac
is intact, application of topical agents and dressing changes for initial nonoperative manage‐
ment of a giant omphalocele is recommended. This technique transitions to delayed closure
[26]. Tension and intraabdominal compression increase morbidity and must be avoided during
closure. If tension exists, then a silo or mesh must be used for coverage [38].
In two recent series, infants with giant omphaloceles underwent treatment of the sac with
topical agents and delayed closure. The median age of repair was 10 months (range: 3.4–23.6
months) in one series and 215 days in the other. No repairs were opened postoperatively [4,
22]. Six-month survival was 80% in both the series, despite the fact that half of the delayed
closure infants in one series met the criteria for pulmonary hypoplasia on fetal magnetic
resonance imaging [22].
A recent series of 16 infants with giant omphaloceles achieved discharge and returned for
delayed closure during an elective admission at a median of 14 months (range: 2–28 months).
The median length of hospital stay for this elective admission was 4 days (range: 2–21 days).
One of sixteen (6%) required unexpected prolonged ventilation and stayed in hospital for 21
days. Four (25%) required mesh as viscero-abdominal disproportion had not resolved [26].
When compared to the reports obtained from previous decades, surgeons wait 7–24 months
longer before attempting closure of a giant omphalocele. Although no comparative studies
exist, the concept of giant omphalocele closure has evolved over the last two decades [38, 39].
Most surgeons promote application of topical agents to the sac, followed by delayed closure.
This approach allows improved respiratory status, fewer complications, and better outcomes
Complication N (%)
Wound dehiscence 7 (24%)
Gastroesophageal reflux 5 (17%)
Hepatic hematoma 3 (10%)
Hepatic congestion 2 (6%)
Enterocutaneous fistula 2 (6%)
Bowel infarction 1 (3%)
Renal failure 1 (3%)
Table 3. Operative complications [44].
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[1, 4, 22, 26]. The emphasis on closure has been replaced by a better appreciation of viscero-
abdominal disproportion, abdominal compartment syndrome, and the connection between
stable cardiopulmonary status and survival.
Clinicians should be aware, however, that even if closure succeeds, a 40–50% reduction in
respiratory system compliance on the first and second postoperative days after closure of
abdominal wall defects has been demonstrated, as well as a 38% reduction in forced vital
capacity.
Mechanical ventilation, including high-frequency ventilation, may be required after delayed
omphalocele closure [9, 26, 27].
9.1. Technique of delayed repair
After birth, the application of topical povidone-iodine, silver sulfadiazine or bacitracin
ointment and xeroform gauze to the omphalocele sac allows epithelialization. Epithelialization
often occurs within 10 weeks [16]. During this time, the infant can begin intestinal feeding.
As the giant omphalocele infant grows, the viscero-abdominal disproportion gradually
resolves, but the infant must be clinically monitored. Giant omphalocele infants with respira‐
tory distress, pulmonary hypoplasia, pulmonary hypertension, or sepsis will require specific
care strategies, until they meet the criteria for extubation. Surgical closure of the abdominal
fascia is not a priority during this time period.
The respiratory status of some giant omphalocele infants improves to the point that they can
be discharged, followed as an outpatient, and can return for elective closure [26]. When the
omphalocele contents reduce manually into the abdominal cavity with ease, the body cavity
is considered large enough to proceed with operative closure.
If the contents fit, the impact on venous return, renal perfusion, and diaphragmatic excursion
is decreased. After operative closure, the majority of infants are extubated postoperatively,
and the average length of hospital stay is 4 days. A minority of infants may have a longer
ventilator time after closure (up to 21 days), and this can be difficult to predict [4, 26]. Parents
should be informed of this possibility.
9.2. Ruptured omphalocele
A ruptured omphalocele is defined as any disruption of the omphalocele sac membrane [48].
Rupture of the omphalocele sac is frequently reported as a poor prognosticator associated with
sepsis and mortality. The goal of the pediatric surgeon is to cover the eviscerated organs.
Although disrupted, if enough sac exists, it can be successfully sutured together with absorb‐
able sutures.
Successful reduction and coverage of a giant ruptured omphalocele are reported after silo
placement and coverage with an absorbable mesh, followed by split thickness skin grafting
[49]. Despite coverage, many infants die of respiratory insufficiency and infection [28].
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A ruptured sac requires urgent surgical intervention, but only sporadic case reports exist that
pertain to specific surgical management of a ruptured omphalocele.
Hemodynamic instability dominates the clinical course in infants with ruptured omphalocele.
The majority of infants with ruptured omphalocele require at least 80 ml–1 kg–1 volume
expansion in the first 7 days of life [38]. Intestinal exposure results in increased water and heat
loss. Manipulation and closure can result in losses into a third space that exacerbates hypo‐
volemia.
Volume expansion to achieve a mean arterial pressure of 45 mmHg increases blood pressure
and urine output. The use of renal dose dopamine is controversial, and benefits have not been
confirmed in recent meta-analyses. High-dose norepinephrine should be avoided as it can
exacerbate bowel ischemia and necrosis [38].
An infant with ruptured omphalocele requires surgical consultation to obtain organ coverage,
but intensive cardiopulmonary support with features of sepsis and a high mortality rate will
dominate the clinical course. The association between ruptured omphalocele, sepsis, and
mortality is not well understood.
10. Long-term respiratory support
There is a potential need for ongoing mechanical ventilatory support after the neonatal period
in neonates born with a giant omphalocele. Partridge observed high rates of reactive airways
disease in giant omphalocele survivors that was significantly associated with pulmonary
hypertension [31]. Neonates with giant omphalocele and pulmonary hypertension required
increased respiratory support based on the significant increases in the duration of mechanical
ventilation, requirement for high-frequency oscillatory ventilation and tracheostomy, with
dependence on home oxygen therapy following hospital discharge [31].
Whether reactive airways disease is an innate characteristic of the airways of infants with
pulmonary hypoplasia associated with giant omphalocele versus increased respiratory
support requirements and sequelae of mechanical ventilation remains unclear.
Pulmonary function abnormalities have been described in giant omphalocele survivors, and
include reduced mean forced vital capacity and forced expiratory volume on pulmonary
function testing with significant bronchodilator responsiveness in almost half of all patients
studied [31]. Long-term respiratory issues in infants with giant omphaloceles include asthma,
recurrent infections, chronic lung disease, and bronchomalacia.
Prolonged respiratory insufficiency is a frequent complication of giant omphalocele and the
major prognostic factor for infants without life-threatening malformations. Infants with giant
omphaloceles may require support for respiratory insufficiency into their second year of life.
This possibility should be discussed with their families.
Of 22 long-term survivors with giant omphaloceles in a prospective follow-up series, chronic
lung disease exists in 40%, and 16% have a tracheostomy for prolonged ventilation at a mean
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day of life 154 (median: 156 days; range: 100–204 days) [6]. Of six long-term survivors in a
single retrospective series at 33.2 months (range: 20–70 months), three have asthma requiring
medical therapy, two have recurrent infections, and one requires overnight continuous
positive airway pressure (CPAP) at 20 months for bronchomalacia [4].
Not much data are reported about the indications of tracheostomy in neonates with giant
omphalocele, although most retrospective series report a subset that required prolonged
ventilation and tracheostomy placement, in general, 5–10% of infants in a series. In general,
tracheostomies are placed to secure a safe airway for infants with protracted mechanical
ventilation. The optimal timing for tracheostomy placement in these babies is unknown;
however, severity of lung disease and problems of airway that preclude extubation are the
most common indications.
There is no good evidence for deferring tracheostomy because infants are receiving high
ventilator pressures. While high ventilator settings may be a concern that discourages
consideration of tracheostomy placement, appropriate developmental interventions are nearly
impossible to implement without placement of a tracheostomy in infants with an unstable
artificial airway [50].
11. Gastroesophageal reflux disease (GERD)
In infants with omphaloceles, the incidence of gastroesophageal reflux disease (GERD) with
associated esophagitis approaches 45% [51]. Gastroesophageal reflux disease is diagnosed at
a median age of 7 months and is more prevalent in infants with giant defects. Infants with
omphalocele and a large defect have a high incidence of GERD complicated by esophagitis
during the first few years of life [51].
Frequently, the retrospective series reports infants with omphaloceles and GERD that fail
medical therapy and undergo Nissen fundoplication [6].
Pulmonary function studies were performed on follow-up of 30 giant omphalocele infants at
a median of 19 months. The studies performed were spirometry, fractional lung volume
measurements, assessment of bronchodilator responsiveness and passive respiratory mechan‐
ics, to evaluate the nature and degree of pulmonary dysfunction in these survivors. The series
reports lung volume restriction without obstruction, an increased likelihood of airway
hyperresponsiveness and reduced compliance in almost 50% of the infants studied [31, 52].
Early recognition of pulmonary functional impairment may help develop targeted treatment
strategies for these infants, and this may include evaluation and treatment for GERD.
Partridge reports similar high rates of reactive airways disease in giant omphalocele survivors.
Follow-up pulmonary function study results are similar to those obtained for infants with
congenital diaphragmatic hernia and bronchopulmonary dysplasia. There may be a common
etiology between pulmonary hypoplasia and reactive airways disease. The same series of
omphalocele infants also reports a 10% rate of Nissen fundoplication for symptomatic GERD.
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Targeted treatment strategies are not well established, but GERD will exacerbate hyperactive
airways and asthma. Evidence for GERD should be sought by pH probe studies or endoscopy
to diagnose esophagitis in infants with omphaloceles. Contrast radiographs may also add
information regarding the esophageal-gastric anatomy and the presence of GERD. Any
contribution of GERD to airway responsiveness should decrease with appropriate medical
and/or surgical therapy.
12. Prematurity
In the majority of series that examine outcomes in omphalocele infants and factors associated
with mortality, when factors such as respiratory insufficiency, pulmonary hypertension, and
measures of pulmonary hypoplasia are examined, the influence of prematurity (defined as an
infant born before 37 weeks gestation) is rarely as preponderant as other respiratory comor‐
bidities. In the first series that reported respiratory insufficiency as an independent predictor
of mortality in omphalocele infants, respiratory insufficiency at birth was found to be inde‐
pendent of gestational age [1].
In a recent multicenter series of 51 infants that found pulmonary hypertension and respiratory
insufficiency at birth were associated with mortality in omphalocele infants, the median
gestational age was 38.2 weeks (range: 28.0–40.0 weeks) for survivors and 34.6 weeks (range:
29.0–40.4 weeks) for mortalities [28]. There was no significant difference in gestational age
between survivors and nonsurvivors. Respiratory insufficiency and pulmonary hypertension
were associated with mortality, independent of gestational age. Of seven infants with respi‐
ratory insufficiency at birth, but without evidence of pulmonary hypertension, six survived.
None of the remaining 44 infants in the series were premature. There was no significant
association between prematurity, respiratory insufficiency, and mortality that could be
identified in these infants with omphaloceles [28].
In contrast, in one study from Porter, preterm birth complicated more than a third of ompha‐
locele cases, and the only neonatal deaths occurred because of complications of prematurity
[53]. This is an isolated report.
Another series reports that the presence of major anomalies was the most significant factor
associated with pulmonary morbidity, independent of gestational age [19].
For the majority of series that examine the influence of various factors on respiratory insuffi‐
ciency, morbidity, and mortality in omphalocele infants, the influence of prematurity is not as
predominant as other factors. This is likely because the median gestational age for most series
is closer to term as modern prenatal care and monitoring of high-risk pregnancies may prevent
preterm birth. For infants that are premature, if there is no pulmonary hypertension or
pulmonary hypoplasia, the modern neonatal care of premature infant lungs is now sophisti‐
cated to the point that an influence on mortality cannot be consistently identified in the
retrospective series.
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13. Conclusions
Despite advances in neonatal care, mortality rates for infants with omphaloceles remain
between 5% and 25% [4]. In this chapter, the unique aspects of respiratory management in
omphalocele infants and care strategies are discussed. The chapter emphasizes pulmonary
hypoplasia as distinct from pulmonary hypertension. Pulmonary hypoplasia is defined as
insufficient development of pulmonary airways, alveoli, and vessels. Fetal MRI after 26 weeks
gestational age with calculation of the O/E-TFLV is recommended. A prenatal O/E-TFLV of
less than 50% predicts lower Apgar scores and a longer duration of mechanical ventilation. It
may eventually prognosticate for mortality.
Pulmonary hypertension is an independent predictor of mortality in omphalocele infants [28].
A relationship may exist between giant defects and abnormal pulmonary vascular tone.
Respiratory insufficiency and pulmonary hypertension, not the defect diameter, are the
prognosticators to identify [8, 18, 32]. We recommend echocardiography between days 2 and
7 of life to evaluate for pulmonary hypertension. After diagnosis, echocardiography should
be performed at regular intervals, until stabilization is demonstrated [28, 30].
Assisted-ventilation concepts in omphalocele infants are similar for all neonates with respira‐
tory compromise. Gentle ventilation, adequate gas exchange, and early extubation minimize
adverse outcomes. A longer duration of ventilation is associated with chronic lung disease,
sepsis, and neurodevelopmental impairment [6]. Infants with giant omphaloceles represent a
subgroup that benefit from these concepts. They frequently have several comorbidities and a
longer period of respiratory insufficiency after birth.
Review of the ELSO database reveals that for infants with omphaloceles requiring ECMO,
between 2011 and 2015, the mortality is estimated at 80%. Clinicians should consider these
results before recommending ECMO. The surgical approach for infants with omphaloceles has
evolved over the last two decades. The emphasis on primary closure is now replaced by an
appreciation of viscero-abdominal disproportion and abdominal compartment syndrome [1,
4, 22, 26].
Respiratory management for infants with omphaloceles may be arduous. Application of
specific definitions allows targeting of therapy and clinical strategies. A multidisciplinary
approach by perinatology, pediatric surgery, and neonatology may allow comprehensive
evaluation of respiratory status. Analysis of prenatal information followed by postnatal clinical
correlation may improve the outcomes for infants with omphaloceles.
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